Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
1.
Science ; 212(4493): 471-2, 1981 Apr 24.
Artigo em Inglês | MEDLINE | ID: mdl-6259737

RESUMO

Thirty minutes after inoculation of reovirus type 1 into the intestinal lumen of the mouse, viruses were found adhering to the surface of intestinal M cells but not other epithelial cells. Within 1 hour, viruses were seen in the M cell cytoplasm and were associated with mononuclear cells in the intercellular space adjacent to the M cell. These findings suggest that M cells are the site where reovirus penetrates the intestinal epithelium.


Assuntos
Mucosa Intestinal/microbiologia , Infecções por Reoviridae/patologia , Reoviridae/fisiologia , Animais , Animais Lactentes/microbiologia , Endocitose , Espaço Extracelular/microbiologia , Mucosa Intestinal/citologia , Camundongos , Nódulos Linfáticos Agregados/microbiologia , Receptores Virais/metabolismo
2.
Transplantation ; 53(2): 428-32, 1992 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-1346731

RESUMO

RS-61443, a morpholinoethyl ester of mycophenolic acid, inhibits the synthesis of guanosine monophosphate, which plays a pivotal role in lymphocyte metabolism. The drug blocks proliferative responses of T and B lymphocytes, and inhibits antibody formation and the generation of cytotoxic T cells. In vivo, RS-61443 prolongs the survival of islet allografts in mice, heart allografts in rats, and kidney allografts in dogs. Reversal of ongoing acute rejection was demonstrated in rat heart allografts and kidney allografts in dogs. Preliminary evidence suggests that the drug prevents chronic rejection. The purpose of this study was to test the safety and tolerance in patients receiving primary cadaver kidneys. RS-61443 in doses from 100 mg/day p.o. to 3500 mg/day p.o. was given to patients in combination with cyclosporine and prednisone. Further study goals were to evaluate the pharmacokinetics of RS-61443, watch for the occurrence of opportunistic infections and acute rejection, and establish dosages for further clinical trials. Forty-eight patients were entered, with six patients in each dose group. RS-61443 was well tolerated in all dose groups, with only one adverse event possibly related to the drug (hemorrhagic gastritis). There was a statistically significant correlation between rejection episodes and dose (P = 0.022), patients with rejection episodes versus dose (P = 0.038), and number of OKT3/prednisone courses versus dose (P = 0.008). There was no overt nephrotoxicity or hepatotoxicity. Preliminary results of a rescue trial in 20 patients with kidney transplants will also be presented.


Assuntos
Imunossupressores/normas , Ácido Micofenólico/análogos & derivados , Adulto , Idoso , Creatinina/sangue , Relação Dose-Resposta a Droga , Avaliação de Medicamentos , Tolerância a Medicamentos , Feminino , Rejeição de Enxerto/efeitos dos fármacos , Humanos , Imunossupressores/administração & dosagem , Imunossupressores/farmacocinética , Transplante de Rim/imunologia , L-Lactato Desidrogenase/sangue , Contagem de Leucócitos , Lipase/sangue , Masculino , Pessoa de Meia-Idade , Ácido Micofenólico/administração & dosagem , Ácido Micofenólico/farmacocinética , Ácido Micofenólico/normas , Projetos Piloto , gama-Glutamiltransferase/sangue
3.
Transplantation ; 56(1): 75-82, 1993 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8333071

RESUMO

Mycophenolate mofetil is a potent inhibitor of de novo guanine nucleotide synthesis that selectively blocks lymphocyte proliferative responses. In animal models, mycophenolate mofetil has been shown to prolong allograft survival, reverse ongoing rejection, and induce strain-specific tolerance. To assess the safety and efficacy of mycophenolate mofetil in cardiac transplantation, 30 recipients with mild rejection were enrolled in an 8-week phase I trial. Mycophenolate mofetil in doses from 500 to 3000 mg/day orally was substituted for azathioprine, while baseline cyclosporine levels and corticosteroid doses were maintained. Rejection resolved in the majority of patients, with a significant decrease in mean biopsy score. By protocol, mycophenolate mofetil was discontinued in 4 patients due to persistent mild rejection, and in 4 patients due to progression to moderate rejection. The rate of progression to moderate rejection compared favorably with that observed in patients with mild rejection maintained on azathioprine without augmentation of immunosuppression. Significant increases were observed in hematocrit, total white blood cell count, and absolute neutrophil count. Absolute lymphocyte count remained unchanged. No nephrotoxicity or hepatotoxicity was observed. Gastrointestinal side effects prompted discontinuation of mycophenolate mofetil in one patient. Two major infections occurred. Mycophenolate mofetil remained well tolerated during long-term maintenance immunosuppression, with a rate of rejection similar to that in patients receiving azathioprine. We conclude that mycophenolate mofetil is safe and well tolerated in cardiac transplant recipients, is less myelosuppressive than azathioprine, and appears to be at least equipotent to azathioprine.


Assuntos
Rejeição de Enxerto/tratamento farmacológico , Transplante de Coração , Imunossupressores/toxicidade , Ácido Micofenólico/análogos & derivados , Adulto , Biópsia , Feminino , Rejeição de Enxerto/patologia , Transplante de Coração/patologia , Transplante de Coração/fisiologia , Humanos , Testes de Função Hepática , Masculino , Ácido Micofenólico/uso terapêutico , Ácido Micofenólico/toxicidade
4.
J Heart Lung Transplant ; 13(3): 444-50, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-8061021

RESUMO

Mycophenolate mofetil (RS-61443), a derivative of mycophenolic acid, is a new immunosuppressive agent that inhibits de novo purine synthesis in activated lymphocytes. In a clinical trial of mycophenolate mofetil in the treatment of recurrent or persistent heart rejection, 17 patients 0.6 to 104 months (median 5.4 months) after transplantation received a daily oral dose of mycophenolate mofetil of 3000 mg, with seven patients increasing to 3500 mg daily. Azathioprine was routinely discontinued at the start of mycophenolate mofetil treatment. One patient in shock from acute rejection required retransplantation before starting mycophenolate mofetil and died 68 days later of cytomegalovirus sepsis. Another patient died 72 days after mycophenolate mofetil of protracted multisystem failure (present before mycophenolate mofetil). One patient required early cessation of mycophenolate mofetil, and the other 14 patients were alive and well 5 to 10 months after initiating mycophenolate mofetil treatment. Three patients required transient dose reduction and one patient required discontinuation of mycophenolate mofetil because of nausea, diarrhea, or abdominal cramps. No other clinical side effects were noted. Frequency of rejection decreased from 0.67 rejection episodes per patient per month before mycophenolate mofetil to 0.27 rejection episodes per patient per month after mycophenolate mofetil (p < 0.0001). Frequency of infection was unchanged after mycophenolate mofetil (p = 0.9). Renal function was not affected by mycophenolate mofetil (creatinine clearance 1.8 mg/dl before mycophenolate mofetil vs 1.7 mg/dl after mycophenolate mofetil; p = 0.03).(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Rejeição de Enxerto/tratamento farmacológico , Transplante de Coração/efeitos adversos , Imunossupressores/uso terapêutico , Ácido Micofenólico/análogos & derivados , Administração Oral , Adulto , Idoso , Biópsia , Medula Óssea/efeitos dos fármacos , Causas de Morte , Feminino , Seguimentos , Rejeição de Enxerto/patologia , Humanos , Imunossupressores/administração & dosagem , Imunossupressores/efeitos adversos , Infecções , Rim/efeitos dos fármacos , Fígado/efeitos dos fármacos , Masculino , Metilprednisolona/uso terapêutico , Pessoa de Meia-Idade , Muromonab-CD3/uso terapêutico , Ácido Micofenólico/administração & dosagem , Ácido Micofenólico/efeitos adversos , Ácido Micofenólico/uso terapêutico , Recidiva , Fatores de Tempo
5.
Fertil Steril ; 56(2): 235-41, 1991 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-2070852

RESUMO

STUDY OBJECTIVE: To identify and characterize the antiendometrial tissue specific antibody response in endometriosis patients. DESIGN: Retrospective. SETTING: Industrial research laboratory. PATIENTS: Twenty untreated women with laparoscopically diagnosed endometriosis, 10 healthy women without symptoms of endometriosis, 12 women in whom laparoscopy failed to yield evidence of endometriosis, 10 healthy men, and 4 individuals with elevated titers of serum antinuclear antibodies. RESULTS: Several immunological methods have been employed including immunofluorescence, hemagglutination, enzyme-linked immunoabsorbent assays, and protein blotting. Contrary to reports in the literature, results of these analyses have failed to demonstrate the presence of detectable levels of antiendometrial immunoreactivity in sera from patients with endometriosis. CONCLUSION: The association of endometrial autoimmunity with endometriosis remains to be established.


Assuntos
Autoanticorpos/sangue , Endometriose/imunologia , Endométrio/imunologia , Western Blotting , Ensaio de Imunoadsorção Enzimática , Feminino , Imunofluorescência , Testes de Hemaglutinação , Humanos , Estudos Retrospectivos
9.
J Virol ; 19(2): 643-58, 1976 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-957484

RESUMO

Infection of KB cells at 39.5 degrees C with H5ts147, a temperature-sensitive (ts) mutant of type 5 adenovirus, resulted in the cytoplasmic accumulation of hexon antigen; all other virion proteins measured, however, were normally transported into the nucleus. Immunofluorescence techniques were used to study the intracellular location of viral proteins. Genetic studies revealed that H5ts147 was the single member of a nonoverlapping complementation group and occupied a unique locus on the adenovirus genetic map, distinct from mutants that failed to produce immunologically reactive hexons at 39.5 degrees C ("hexon-minus" mutants). Sedimentation studies of extracts of H5ts147-infected cells cultured and labeled at 39.5 degrees C revealed the production of 12S hexon capsomers (the native, trimeric structures), which were immunoprecipitable to the same extent as hexons synthesized in wild type (WT)-infected cells. In contrast, only 3.4S polypeptide chains were found in extracts of cells infected with the class of mutants unable to produce immunologically reactive hexon protein at 39.5 degrees C. Hexons synthesized in H5ts147-infected cells at 39.5 degrees C were capable of being assembled into virions, to the same extent as hexons synthesized in WT-infected cells, when the temperature was shifted down to the permissive temperature, 32 degrees C. Infectious virus production was initiated within 2 to 6 h after shift-down to 32 degrees C; de novo protein synthesis was required to allow this increase in viral titer. If ts147-infected cells were shifted up to 39.5 degrees C late in the viral multiplication cycle, viral production was arrested within 1 to 2 h. The kinetics of shutoff was similar to that of a WT-infected culture treated with cycloheximide at the time of shift-up. The P-VI nonvirion polypeptide, the precursor to virion protein VI, was unstable at 39.5 degrees C, whereas the hexon polypeptide was not degraded during the chase. It appears that there is a structural requirement for the transport of hexons into the nucleus more stringent than the acquisition of immunological reactivity and folding into the 12S form.


Assuntos
Adenoviridae/metabolismo , Capsídeo/metabolismo , Mutação , Proteínas Virais/metabolismo , Adenoviridae/imunologia , Antígenos Virais/isolamento & purificação , Capsídeo/biossíntese , Capsídeo/imunologia , Linhagem Celular , Núcleo Celular/metabolismo , Cicloeximida/farmacologia , Biossíntese Peptídica , Precursores de Proteínas/biossíntese , Temperatura , Proteínas Virais/biossíntese
10.
J Immunol ; 127(6): 2334-9, 1981 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-6271871

RESUMO

The cellular requirements for the development of an immune response to reovirus type 1 and the role of such a response in the clearance of a primary infection with that virus were explored. An Ia-bearing antigen-presenting cell requirement is demonstrated for the in vitro generation of secondary anti-reovirus cytolytic T lymphocytes (CTL). It is then shown that mice whose spleens are depleted of Ia-bearing adherent cells by exposure in vivo to ultraviolet (UV) radiation exhibit depressed priming for reovirus-specific T lymphocyte function-CTL generation, delayed-type hypersensitivity reactivity, and T cell proliferative responsiveness. These UV-irradiated mice clear primary systemic reovirus infections as readily as normal mice. Further, athymic 'nude' mice show no defect in their ability to clear a reovirus infection. The implications of these findings for our understanding of the role of virus-specific T cell function in the clearance of systemic viral infections are discussed.


Assuntos
Infecções por Reoviridae/imunologia , Linfócitos T/imunologia , Animais , Adesão Celular , Citotoxicidade Imunológica , Antígenos de Histocompatibilidade Classe II , Imunidade Celular/efeitos da radiação , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C3H , Camundongos Nus , Reoviridae/imunologia , Linfócitos T/efeitos da radiação , Raios Ultravioleta
11.
Virology ; 131(1): 71-8, 1983 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-6649415

RESUMO

We have examined the evolution of reovirus in two independently established persistently infected (p.i.) cell lines. We found that reovirus undergoes extensive mutation during persistent infection in L cells. However, there was no consistent pattern of virus evolution; in one p.i. cell line temperature-sensitive (ts) mutants were selected, whereas cold-sensitive (cs) mutants were isolated from the second p.i. culture. Neither the cs nor the ts mutants isolated from the carrier cultures expressed their defect at 37 degrees, the temperature at which the p.i. cells were maintained, indicating that the cs and ts phenotypes were nonselected markers. These results emphasize the point that emergence of the ts or cs mutants during persistent infection only signifies that the virus has changed; it does not necessarily imply that the particular mutant is essential for the maintenance of the persistent infection. Given the high mutation rate of viruses, and the wide spectrum of viral mutants present in carrier cultures, it is essential to distinguish the relevant changes from those which may simply represent an epiphenomenon. In the accompanying paper (R. S. Kauffman, R. Ahmed, and B. N. Fields Virology, 130, 79-87, 1983), we show that by using a genetic approach, it is possible to identify the viral gene(s) which are critical for the maintenance of persistent reovirus infection.


Assuntos
Transformação Celular Viral , Variação Genética , Mutação , Reoviridae/genética , Animais , Temperatura Baixa , Células L/microbiologia , Orthoreovirus Mamífero 3/genética , Orthoreovirus Mamífero 3/isolamento & purificação , Camundongos , Reoviridae/isolamento & purificação , Temperatura
12.
Virology ; 131(1): 79-87, 1983 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-6649416

RESUMO

LR-7 cells, variant L cells derived from a type 3 reovirus persistently infected (p.i.) carrier culture (R. Ahmed, W. M. Canning, R. S. Kauffman, A. H. Sharpe, J. V. Hallum, and B. N. Fields, Cell 25, 325-332, 1983) were used to define the viral genes critical for maintenance of the persistent state. A cloned viral isolate (L/C virus) derived from the p.i. culture replicated normally in LR-7 cells, while wild-type (wt) viruses of the three reovirus serotypes replicated less efficiently. To identify the viral gene(s) permitting enhanced replication of L/C virus in LR-7 cells, viral reassortants were prepared by mixed infection of L cells with L/C virus and type 1 wt. Study of the one-step growth curves and final yields of large numbers of reassortants in both L cells and LR-7 cells revealed that the presence of the S1 gene from L/C virus was critical for normal viral replication in LR-7 cells. However, this phenotype was suppressed by the simultaneous presence in reassortants of both the M2 and S4 genes from the type 1 wt parent. The critical change in the S1 gene occurred by passage 13 (63 days) after initiation of the carrier culture. Although multiple mutations are present in the viral population from p.i. cultures, certain specific mutations can be identified as critical for maintenance of the persistent state.


Assuntos
Transformação Celular Viral , Genes Virais , Orthoreovirus Mamífero 3/genética , Mutação , Reoviridae/genética , Seleção Genética , Animais , Divisão Celular , Cinética , Células L/microbiologia , Células L/fisiologia , Camundongos , Replicação Viral
13.
Virology ; 131(2): 265-73, 1983 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-6318431

RESUMO

The virological requirements for the recognition of infected target cells by cytolytic T lymphocytes (CTL), using reovirus, a nonenveloped, icosahedral virus has been investigated. Using mouse L cells infected at the nonpermissive temperature with ts (temperature-sensitive) mutants of reovirus in complementation groups C and G, it has been shown that the production of complete viral particles is not necessary for efficient lysis of infected cells by CTL. In addition, adsorption of purified viral particles and viral top component (TC), empty capsids lacking genome ds-RNA, to L cells just prior to use in cytolytic T cell assays is sufficient to produce target cells capable of being lysed, though target production is less efficient than with L cells infected with reovirus. Membrane fluorescence analysis of cells infected with reovirus ts mutants at the nonpermissive temperature and with adsorbed viral particles revealed the presence of the viral sigma 1 protein on the cell surface. For adsorbed particles, the degree of membrane fluorescence paralleled the capacity of CTL to lyse target cells. It is concluded that cells infected with icosahedral, nonenveloped viruses, like cells infected with enveloped viruses, express viral antigens on the cell surface even in the absence of the production of complete viral particles; adsorbed viral particles can be incorporated into the cell membrane in a manner sufficient for recognition and lysis by CTL, in the absence of actual infection of the cells.


Assuntos
Orthoreovirus Mamífero 3/patogenicidade , Infecções por Reoviridae/microbiologia , Reoviridae/patogenicidade , Linfócitos T Citotóxicos/microbiologia , Proteínas Virais/imunologia , Vírion/patogenicidade , Adsorção , Animais , Imunofluorescência , Imunização , Células L/imunologia , Células L/microbiologia , Orthoreovirus Mamífero 3/imunologia , Camundongos , Camundongos Endogâmicos C3H , Mutação , Infecções por Reoviridae/imunologia , Linfócitos T Citotóxicos/imunologia , Temperatura , Ensaio de Placa Viral , Vírion/imunologia
14.
J Immunol ; 129(6): 2396-401, 1982 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-6292289

RESUMO

We have previously reported that mice with defective T lymphocyte function clear a primary reovirus type 1 infection in a normal fashion. The present studies were initiated to determine what cells may play a role in the clearance of this primary infection. We show that macrophages from unprimed mice are capable of lysing reovirus type 1-infected target cells in the absence of specific antibody. Macrophages from nu/nu mice have higher levels of this lytic activity than macrophages from nu/+ and normal mice. In addition, PEC from endotoxin nonresponsive C3H/HeJ mice have virtually no anti-viral lytic activity, while PEC from C3H/FeJ mice have high levels of such activity. Incubation of PEC from C3H/HeJ mice overnight in Con A supernatants restores this lytic activity. PEC are capable of lysing reovirus type 1-infected target cells but not those infected with type 3 reovirus. Using intertypic recombinant viruses, we show this striking target cell specificity to be a property of the sigma 1 protein, the viral hemagglutinin.


Assuntos
Citotoxicidade Imunológica , Imunidade Celular , Macrófagos/imunologia , Infecções por Reoviridae/imunologia , Animais , Antígenos Virais , Hemaglutininas Virais/imunologia , Antígenos de Histocompatibilidade Classe II/análise , Células L , Camundongos , Camundongos Endogâmicos C3H/imunologia , Camundongos Nus/imunologia , Baço/imunologia , Linfócitos T/imunologia
15.
J Infect Dis ; 156(4): 575-81, 1987 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-3305720

RESUMO

We determined the sensitivity, specificity, and predictive value of a direct fluorescence test for Chlamydia trachomatis infection compared with culture of the endocervix in women seeking routine gynecologic care. Of 527 patients seen in a hospital-based practice, 23 (4.4%) had a positive culture for C. trachomatis. The overall sensitivity of the direct test was 70%, and the specificity was 98%. When five or more endocervical cells were present on the direct test slide, the sensitivity increased to 92%, and the specificity decreased to 96% (P less than .05). When the presence of any columnar epithelial cells, five or more elementary bodies, or both was used as the criteria for accepting specimens, the sensitivity and specificity of the direct test were 80% and 96%, respectively. However, 44% of the specimens would be rejected if these criteria were used. The overall probability that an individual with a positive direct test would have a positive culture was 62%.


Assuntos
Infecções por Chlamydia/diagnóstico , Imunofluorescência , Doenças do Colo do Útero/diagnóstico , Adulto , Colo do Útero/microbiologia , Chlamydia trachomatis , Feminino , Humanos , Pessoa de Meia-Idade , Valor Preditivo dos Testes
16.
Virology ; 124(2): 403-10, 1983 Jan 30.
Artigo em Inglês | MEDLINE | ID: mdl-6823749

RESUMO

After intragastric inoculation of adult mice, type 1 reovirus was initially concentrated in Peyer's patches over the first 4 hr after inoculation, then spread sequentially to the mesenteric lymph nodes and spleen. For type 3 reovirus, however, initial entry into Peyer's patches in adult mice was followed by loss of viral infectivity so that by 4 hr after inoculation virtually no infectious virus was detected in the intestine, and spread to extraintestinal tissues did not occur. In 10-day-old mice, type 3 was capable of spread to the mesenteric lymph nodes but not the spleen. Thus, as animals aged there was a greater restriction of the spread of type 3 from the intestine. Studies using a field isolate of type 3 reovirus that is resistant to intestinal proteases, and genetic studies utilizing type 1 x type 3 viral reassortants, revealed that the viral sigma 1 protein determined the capacity of reovirus to spread from the intestine in both adult and 10-day-old mice. Thus, the interaction of reovirus with host defense mechanisms, and the age-dependent restriction of spread of type 3 reovirus from the intestine are mediated by the viral sigma 1 protein.


Assuntos
Hemaglutininas Virais , Intestinos/microbiologia , Linfonodos/microbiologia , Reoviridae/patogenicidade , Baço/microbiologia , Envelhecimento , Animais , Animais Lactentes , Capsídeo/fisiologia , Orthoreovirus Mamífero 3/patogenicidade , Camundongos , Camundongos Endogâmicos C3H , Nódulos Linfáticos Agregados/microbiologia , Proteínas Virais/fisiologia
17.
J Immunol ; 129(2): 900-3, 1982 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-6282974

RESUMO

By fusing primed murine lymphocytes with a syngeneic T cell lymphoma, we have been able to select for H-2-restricted, virus-specific cytotoxic T cell hybridomas (CTH). These T cell hybrids, which replicate in ordinary tissue culture medium or in ascites, are capable of lysing virally infected target cells, and their activity is facilitated by the presence of lectins in the assay medium. Unlike cells mediating lectin nonspecific lysis, these hybridomas are H-2 restricted and specific for single viral proteins. The ability to maintain these cells in culture for over 18 mo and to pass them in vivo without loss of activity or specificity indicates that they will provide sufficient material for the analysis of surface proteins and genetic information required for the recognition and lysis of virally infected cells by killer T cells.


Assuntos
Citotoxicidade Imunológica , Hibridomas/imunologia , Linfoma/imunologia , Linfócitos T/imunologia , Animais , Concanavalina A/farmacologia , Feminino , Antígenos H-2/genética , Antígenos H-2/imunologia , Camundongos , Camundongos Endogâmicos C3H , Infecções por Reoviridae/imunologia
18.
Transpl Int ; 5 Suppl 1: S448-9, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-14621842

RESUMO

RS-61443, the morpholinoethyl ester of mycophenolic acid (mPA), is a potent, noncompetitive, reversible inhibitor of eucaryotic inosine monophosphate (IMP) dehydrogenases. Because of the importance of the guanosine and deoxyguanosine nucleotides in activating phosphoribosyl pyrophosphate (PRPP) synthesis and ribonucleotide reductase, respectively, it was postulated that depletion of GMP (and consequently GTP and GDP) would have antiproliferative effects on lymphocytes. Furthermore, since lymphocytes rely on de novo pruine synthesis whereas other cell types do not, antiproliferative effects produced in this way are more selective for lymphocytes than other cell types.


Assuntos
Rejeição de Enxerto/tratamento farmacológico , Imunossupressores/uso terapêutico , Transplante de Rim/imunologia , Ácido Micofenólico/análogos & derivados , Ácido Micofenólico/uso terapêutico , Corticosteroides/uso terapêutico , Cadáver , Quimioterapia Combinada , Inibidores Enzimáticos/uso terapêutico , Humanos , IMP Desidrogenase/antagonistas & inibidores , Imunossupressores/efeitos adversos , Doadores Vivos , Muromonab-CD3/uso terapêutico , Ácido Micofenólico/efeitos adversos , Doadores de Tecidos
19.
J Immunol ; 131(5): 2539-41, 1983 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-6313806

RESUMO

A monoclonal anti-idiotypic antibody directed against an idiotypic determinant on a monoclonal anti-reovirus type 3 hemagglutinin antibody with viral neutralization activity is capable of binding to the surface of lymphoid cells (BW5147, R.1.1, and R1.E) and of inhibiting viral binding to cell surface receptors. The inhibition of viral binding was specific for the anti-idiotype antibody; viral binding was not inhibited by antibodies bound to the H-2k and Thy-1.2 antigens on the surface. Viral binding to idiotype-negative cells (P-815, EL-4) was not inhibited by the anti-idiotypic antibody, although these cells are susceptible to type 3 reovirus infection. These data suggest that there are at least two structural classes of type 3 reovirus receptors on murine cells. It is probable that anti-idiotypic antibodies of this type will be useful in studying the structure and regulation of viral receptors on cell surfaces and for the purification of these receptors, and may provide a way to block viral infection.


Assuntos
Anticorpos Anti-Idiotípicos/fisiologia , Anticorpos Monoclonais/fisiologia , Receptores Virais/metabolismo , Infecções por Reoviridae/imunologia , Animais , Anticorpos Anti-Idiotípicos/imunologia , Anticorpos Monoclonais/imunologia , Sítios de Ligação de Anticorpos , Ligação Competitiva , Idiótipos de Imunoglobulinas/imunologia , Linfoma/complicações , Linfoma/metabolismo , Orthoreovirus Mamífero 3/metabolismo , Sarcoma de Mastócitos/complicações , Sarcoma de Mastócitos/metabolismo , Camundongos , Receptores Virais/análise , Infecções por Reoviridae/complicações , Infecções por Reoviridae/microbiologia , Timoma/complicações , Timoma/metabolismo
20.
Cell ; 25(2): 325-32, 1981 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-7285112

RESUMO

Mutant L cells, designated LR cells, were isolated after "curing" a persistently infected cell line (L/C) with antireovirus serum. The LR cells were shown to be virus-free; no reovirus was detectable by infectious center assays, plaque assays, presence of viral proteins, presence of viral dsRNA and immunofluorescence studies. Persistent infections were readily established n LR cells following infection with either cloned, low passage wild-type reovirus or cloned, low passage reovirus isolated from carrier cultures. Reovirus isolated from carrier cultures, however, grew much better than wild-type reovirus in LR cells and showed complete dominance over wild-type reovirus in coinfection experiments. Infection of LR cells with wild-type reovirus resulted in a low-level persistent infection with inefficient viral replication; these mutant L cells were partially resistant to infection with wild-type reovirus. In contrast, infection of the mutant L cells with virus isolated from the persistently infected cells resulted in a persistent infection accompanied with efficient viral replication. Infection of the original L cells with either wild-type reovirus or reovirus isolated from the persistently infected cells resulted in a lytic infection with no surviving cells. Thus the host cell plays a crucial role in the maintenance of persistent reovirus infection. Our results show that there is a coevolution of both mutant L cells and mutant reovirus during persistent infection.


Assuntos
Células L/microbiologia , Orthoreovirus Mamífero 3/crescimento & desenvolvimento , Reoviridae/crescimento & desenvolvimento , Animais , Células Clonais , Efeito Citopatogênico Viral , Orthoreovirus Mamífero 3/genética , Camundongos , Mutação , Reoviridae/genética , Replicação Viral
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA